Collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours, vaccination status and intentions to get vaccinated. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between November 2020 and April 2021, with the vast majority of collection occurring in January and February 2021. Cycle 2 was from May to September 2022.
